AstraZeneca CEO Pascal Soriot Highlights U.S. Drug-Pricing Challenges and High-Pressure Corporate Culture
Pascal Soriot, Chief Executive Officer of AstraZeneca since 2012, has recently drawn attention to two critical challenges facing the global